FLGT Fulgent Genetics, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Fulgent Genetics, Inc. (FLGT) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 27, 2026, a 10-Q quarterly report filed on May 1, 2026, an 8-K current report filed on July 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Fulgent Genetics, Inc. (FLGT) (SEC CIK 1674930), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Fulgent Genetics, Inc.
Ask AI about FLGT filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting FLGT positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on FLGT.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Fulgent Genetics, Inc. (FLGT) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 30, 2026 | - | - | - |
8-K | Jun 2, 2026 | - | - | |
8-K | May 14, 2026 | - | - | |
10-Q | May 1, 2026 | Mar 31, 2026 | - | |
8-K | May 1, 2026 | - | - | - |
8-K | Mar 17, 2026 | - | Analysis | - |
8-K | Feb 27, 2026 | - | Analysis | - |
10-K | Feb 27, 2026 | Dec 31, 2025 | - | |
8-K | Dec 22, 2025 | - | - | |
10-Q | Nov 7, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 1, 2025 | Jun 30, 2025 | - | |
10-Q | May 2, 2025 | Mar 31, 2025 | - | |
10-K | Feb 28, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 8, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 2, 2024 | Jun 30, 2024 | - | |
10-Q | May 3, 2024 | Mar 31, 2024 | - | |
10-K | Feb 28, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 3, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 4, 2023 | Jun 30, 2023 | - | |
10-Q | May 5, 2023 | Mar 31, 2023 | - | |
10-K | Feb 28, 2023 | Dec 31, 2022 | - | |
SC 13G | Jan 20, 2023 | - | - | |
10-Q | Nov 7, 2022 | Sep 30, 2022 | - | |
10-Q | Aug 4, 2022 | Jun 30, 2022 | - | |
10-Q | May 5, 2022 | Mar 31, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate FLGT share value held by 13F filers tracked by SignalX, by quarter.
- Ameriprise Financial+63.9K (+13%)
- State Street Corp+35.7K (+7%)
- Wells Fargo & Co+26.4K (+22%)
- Two Sigma Investments+24.8K (+8%)
- Citigroup+16.8K (+2825%)
- Millennium Management537.6K (-57%)
- Dimensional Fund Advisors217.3K (-24%)
- D.E. Shaw & Co214.5K (-31%)
- BlackRock187.7K (-6%)
- Citadel Advisors LLC186.1K (-71%)
- AQR Capital Management+29.4K
- Franklin Resources+13.8K
- Fifth Third Bancorp+240
- Vanguard Group Inc−1.26M
- JPMorgan Chase & Co−250.1K
- Invesco Ltd−62.0K
- Atlantic Union Bankshares Corp−59
Source: 13F-HR filings on SEC EDGAR (aggregated from 168 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest FLGT SEC filings in 2026?
Fulgent Genetics, Inc. (FLGT) has filed a 10-K annual report on February 27, 2026, a 10-Q quarterly report on May 1, 2026, an 8-K current report on July 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did FLGT file its most recent 10-K annual report?
Fulgent Genetics, Inc. (FLGT) filed its most recent 10-K annual report on February 27, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view FLGT 10-Q quarterly reports?
Fulgent Genetics, Inc. (FLGT)'s most recent 10-Q quarterly report was filed on May 1, 2026. SignalX displays every FLGT 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has FLGT filed recently?
Fulgent Genetics, Inc. (FLGT)'s most recent 8-K was filed on July 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find FLGT insider trading activity (Form 4)?
SignalX aggregates every FLGT Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does FLGT file with the SEC?
Fulgent Genetics, Inc. (FLGT) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new FLGT filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Fulgent Genetics, Inc. (FLGT).
What is FLGT's SEC CIK number?
Fulgent Genetics, Inc. (FLGT)'s SEC CIK (Central Index Key) number is 1674930. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1674930 to look up all FLGT filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Fulgent Genetics, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 52+ filings.